[Federal Register Volume 59, Number 240 (Thursday, December 15, 1994)] [Unknown Section] [Page 0] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 94-30871] [[Page Unknown]] [Federal Register: December 15, 1994] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Scientific Misconduct AGENCY: Office of the Secretary, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: Gerald Leisman, Ph.D., New York Chiropractic College: The Division of Research Investigations (DRI) of the Office of Research Integrity (ORI) reviewed an investigation conducted by the New York Chiropractic College (NYCC) into possible scientific misconduct on the part of Gerald Leisman, Ph.D., formerly Director of Research and Institutes at NYCC. ORI found that Dr. Leisman committed scientific misconduct by misrepresenting his academic credentials and professional experience and awards in a grant application (T32 AR07564-01A1) for Public Health Service (PHS) research funds submitted on December 29, 1988. Based upon information obtained by ORI during its oversight review, the ORI found that Dr. Leisman falsely claimed: (1) To have earned a M.D. degree from the University of Manchester (Manchester, England) in 1972; (2) to have held the position of Professor, Neurology and Biomedical Engineering, Harvard University Medical School (June 1982 to January 1987); and (3) to have been awarded inventorship or co-inventorship of thirteen (13) U.S. Patents. Dr. Leisman accepted the ORI findings and agreed to a Voluntary Exclusion agreement under which he is not eligible to apply for or receive any Federal funds in non-procurement transactions (e.g., grants and co-operative agreements) and is not eligible to contract or subcontract with any Federal Government Agency for a three-year period beginning November 28, 1994 and ending November 27, 1997. In addition, Dr. Leisman is prohibited from serving on PHS Advisory Committees, Boards, or peer review groups for a three-year period beginning November 28, 1994 and ending November 27, 1997. FOR FURTHER INFORMATION CONTACT: Director, Division of Research Investigations, Office of Research Integrity, 301-443-5330. Lyle W. Bivens, Ph.D., Director, Office of Research Integrity. [FR Doc. 94-30871 Filed 12-14-94; 8:45 am] BILLING CODE 4160-17-M